Pioglitazone preserves vein graft integrity in a rat aortic interposition model

Journal of Thoracic and Cardiovascular Surgery

Volumn 140, Issue 2, 2010, Pages

  Chen, Zhi ^a   Hasegawa, Tomomi ^a   Tanaka, Akiko ^a   Okita, Yutaka ^a   Okada, Kenji ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

CABG; coronary artery bypass grafting; matrix metalloproteinase; MMP; peroxisome proliferator activated receptor; PPAR; SMA; SMC; smooth muscle actin; smooth muscle cell; TIMP; tissue inhibitor of matrix metalloproteinase

Indexed keywords

EVANS BLUE; GELATINASE A; GELATINASE B; MESSENGER RNA; MYELOPEROXIDASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD FLOW VELOCITY; CONTROLLED STUDY; ENZYME ACTIVITY; FEEDING; FEMORAL VEIN; GRAFT PATENCY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; VEIN GRAFT; ZYMOGRAPHY;

EID: 77955468522     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2009.11.067     Document Type: Article

References (25)

1. G.H. Gibbons, and V.J. Dzau The emerging concept of vascular remodeling N Engl J Med 330 1994 1431 1438
2. J. Goldman, L. Zhong, and S.Q. Liu Degradation of alpha-actin filaments in venous smooth muscle cells in response to mechanical stretch Am J Physiol Heart Circ Physiol 284 2003 H1839 H1847
3. H. Yki-Jarvinen Thiazolidinediones N Engl J Med 351 2004 1106 1118
4. M. Abdelrahman, A. Sivarajah, and C. Thiemermann Beneficial effects of PPAR-gamma ligands in ischemia-reperfusion injury, inflammation and shock Cardiovasc Res 65 2005 772 781
5. T. Kasai, K. Miyauchi, T. Yokoyama, K. Kajimoto, K. Sumiyoshi, and N. Kubota et al. Pioglitazone attenuates neointimal thickening via suppression of the early inflammatory response in a porcine coronary after stenting Atherosclerosis 197 2008 612 619
6. Y. Aizawa, J. Kawabe, N. Hasebe, N. Takehara, and K. Kikuchi Pioglitazone enhances cytokine-induced apoptosis in vascular smooth muscle cells and reduces intimal hyperplasia Circulation 104 2001 455 460
7. T. Nakamura, E. Yamamoto, K. Kataoka, T. Yamashita, Y. Tokutomi, and Y.F. Dong et al. Beneficial effects of pioglitazone on hypertensive cardiovascular injury are enhanced by combination with candesartan Hypertension 51 2008 296 301
8. T. Yoshimoto, M. Naruse, H. Shizume, K. Naruse, A. Tanabe, and M. Tanaka et al. Vasculo-protective effects of insulin sensitizing agent pioglitazone in neointimal thickening and hypertensive vascular hypertrophy Atherosclerosis 145 1999 333 340
9. T. Shiomi, H. Tsutsui, S. Hayashidani, N. Suematsu, M. Ikeuchi, and J. Wen et al. Pioglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates left ventricular remodeling and failure after experimental myocardial infarction Circulation 106 2002 3126 3132
10. Y. Tanaka, T. Hasegawa, Z. Chen, Y. Okita, and K. Okada Renoprotective immunosuppression by pioglitazone with low-dose cyclosporine in rat heart transplantation J Thorac Cardiovasc Surg 138 2009 744 751
11. T. Haraguchi, K. Okada, Y. Tabata, Y. Maniwa, Y. Hayashi, and Y. Okita Controlled release of basic fibroblast growth factor from gelatin hydrogel sheet improves structural and physiological properties of vein graft in rat Arterioscler Thromb Vasc Biol 27 2007 548 555
12. T. Hasegawa, D. Bouis, H. Liao, S.H. Visovatti, and D.J. Pinsky Ecto-5′ nucleotidase (CD73)-mediated adenosine generation and signaling in murine cardiac allograft vasculopathy Circ Res 103 2008 1410 1421
13. T.T. Huynh, M.G. Davies, M.J. Trovato, L. Barber, H.J. Safi, and P.O. Hagen Reduction of lipid peroxidation with intraoperative superoxide dismutase treatment decreases intimal hyperplasia in experimental vein grafts J Surg Res 84 1999 223 232
14. Y. Shi, S. Patel, K.L. Davenpeck, R. Niculescu, E. Rodriguez, and M.G. Magno et al. Oxidative stress and lipid retention in vascular grafts: comparison between venous and arterial conduits Circulation 103 2001 2408 2413
15. A.W. Chung, P. Rauniyar, H. Luo, Y.N. Hsiang, C. van Breemen, and E.B. Okon Pressure distention compared with pharmacologic relaxation in vein grafting upregulates matrix metalloproteinase-2 and -9 J Vasc Surg 42 2005 747 756
16. Q.N. Diep, M. El Mabrouk, J.S. Cohn, D. Endemann, F. Amiri, and A. Virdis et al. Structure, endothelial function, cell growth, and inflammation in blood vessels of angiotensin II-infused rats: role of peroxisome proliferator- activated receptor-gamma Circulation 105 2002 2296 2302
17. A. Jones, R. Deb, E. Torsney, F. Howe, M. Dunkley, and Y. Gnaneswaran et al. Rosiglitazone reduces the development and rupture of experimental aortic aneurysms Circulation 119 2009 3125 3132
18. S.Q. Liu, M.M. Moore, and C. Yap Prevention of mechanical stretch-induced endothelial and smooth muscle cell injury in experimental vein grafts J Biomech Eng 122 2000 31 38
19. T.M. Paravicini, and R.M. Touyz Redox signaling in hypertension Cardiovasc Res 71 2006 247 258
20. K. Satoh, P. Nigro, T. Matoba, M.R. O'Dell, Z. Cui, and X. Shi et al. Cyclophilin A enhances vascular oxidative stress and the development of angiotensin II-induced aortic aneurysms Nat Med 15 2009 649 656
21. P. Human, T. Franz, J. Scherman, L. Moodley, and P. Zilla Dimensional analysis of human saphenous vein grafts: Implications for external mesh support J Thorac Cardiovasc Surg 137 2009 1101 1108
22. S.Z. Duan, M.G. Usher, and R.M. Mortensen Peroxisome proliferator- activated receptor-gamma-mediated effects in the vasculature Circ Res 102 2008 283 294
23. K. Yamashita, H. Murakami, T. Okuda, and M. Motohashi High-performance liquid chromatographic determination of pioglitazone and its metabolites in human serum and urine J Chromatogr B Biomed Appl 677 1996 141 146
24. K. Arii, K. Ota, T. Suehiro, Y. Ikeda, K. Nishimura, and Y. Kumon et al. Pioglitazone prevents reactive hypoglycemia in impaired glucose tolerance Diabetes Res Clin Pract 69 2005 305 308
25. J. Wohrle, N. Marx, W. Koenig, V. Hombach, H.A. Kestler, and M. Hoher et al. Impact of pioglitazone on coronary endothelial function in non-diabetic patients with coronary artery disease Clin Res Cardiol 97 2008 726 733